The rising incidence of cancer, infectious diseases, and genetic disorders; growth in funding for research on genomic, proteomic, and electrophoresis techniques; the growing number of industry-academia research collaborations; growing use of capillary electrophoresis with mass spectroscopy; the increasing use of next-generation sequencing; and rise in the number of clinical, forensic, and research laboratories are factors driving the growth of the electrophoresis market. 

 

The electrophoresis reagents segment accounted for the largest share of the market in 2019. This can be attributed to the increasing use of consumables with the rise in electrophoresis in the fields of proteomics, genomics, drug discovery, antibody development, and personalized medicine, among others. 

 

Also, the increasing demand for 2D electrophoresis for protein separation in a number of applications such as drug discovery, protein mapping, and the diagnosis of chronic diseases, along with the increasing application areas of capillary electrophoresis are supporting market growth. 

 

π†πžπ­ 𝐌𝐨𝐫𝐞 𝐈𝐧𝐬𝐒𝐠𝐑𝐭𝐬, π†π«πšπ› 𝐏𝐃𝐅 @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=434 

 

b0a363ceaeb2016b35dd8108a131b8eb.jpg

The research segment accounted for the largest share of the market in 2019. The large share of this segment can be attributed to the increasing application of electrophoresis in the field of drug discovery, proteomics, genomics, and antibody research. 

 

The academic & research institutes segment accounted for the largest share of the electrophoresis market in 2019. This is primarily attributed to the growing number of industry-academia collaborations and increasing research funding for genomics and proteomics research among academic and research institutes. 

 

Key Market Players

Prominent players in the electrophoresis market are Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Merck Group (Germany), Agilent Technologies (US), Danaher Corporation (US), GE Healthcare (US), PerkinElmer (US), QIAGEN N.V. (Netherlands), Harvard Bioscience (US), Shimadzu Corporation (Japan), Lonza Group (Switzerland), Sebia Group (UK), C.B.S. Scientific Company (US).